AR
ARDT.US Ardent Health Partners, Inc.
- Market cap
- USD 2.51B
- P/E
- 17.1x
- P/B
- 1.78x
- ROE
- 9.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ARDT.US undervalued?
Graham numberARDT.US trades 16.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ardent Health Partners, Inc. fundamental analysis
No fundamental analysis for Ardent Health Partners, Inc. yet.
Ardent Health Partners, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ardent Health Partners, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specia…
Full company profileArdent Health Partners, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ardent Health Partners, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.03B | 2.11B | 3.00B | 4.16B | 4.87B | 5.13B | 5.41B | 5.97B | 6.32B | 6.47B |
| Gross Profit | 2.03B | 2.11B | 3.00B | 4.16B | 3.94B | 4.17B | 5.27B | 4.93B | 6.17B | 802M |
| Operating Income | 126M | 84.8M | 122M | 150M | 437M | 217M | 230M | 406M | 326M | 293M |
| EBITDA | 214M | 143M | 231M | 246M | 527M | 532M | 350M | 575M | 497M | 450M |
| Net Income | -46.4M | 14.6M | -35.6M | -143M | 154M | 189M | 50.3M | 210M | 136M | 135M |
| EPS | -0.33 | 0.10 | -0.25 | -1.01 | 1.08 | 1.32 | 0.35 | 1.58 | 0.96 | 0.95 |
| Balance Sheet | ||||||||||
| Total Assets | - | 1.09B | 2.37B | 2.75B | - | 4.86B | 5.10B | 4.96B | 5.29B | 5.35B |
| Total Liabilities | - | 689M | 1.61B | 2.03B | - | 3.81B | 4.02B | 3.43B | 3.61B | 3.57B |
| Shareholders' Equity | - | 267M | 378M | 332M | - | 639M | 671M | 1.13B | 1.69B | 1.40B |
| Cash & Short-term Investments | - | 92.6M | 72.0M | 59.7M | - | 456M | 438M | 557M | 710M | 766M |
| Total Debt | - | 240M | 953M | 1.26B | - | 2.39B | 2.40B | 2.28B | 2.26B | 2.27B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 120M | 85.8M | 119M | 160M | 147M | -38.4M | 222M | 315M | 471M | 345M |
| Capital Expenditure | 80.5M | 80.5M | 122M | 161M | 139M | 151M | 137M | 188M | 212M | 154M |
| Free Cash Flow | 39.3M | 3.62M | -2.06M | -1.07M | 7.91M | -189M | 84.3M | 128M | 259M | 190M |
| Ratios | ||||||||||
| ROE | - | 5.5% | -9.4% | -43.1% | - | 29.6% | 7.5% | 18.6% | 8.1% | 9.7% |
| ROA | - | 1.3% | -1.5% | -5.2% | - | 3.9% | 1.0% | 4.2% | 2.6% | 2.5% |
| Net Profit Margin | -2.3% | 0.7% | -1.2% | -3.4% | 3.2% | 3.7% | 0.9% | 3.5% | 2.1% | 2.1% |
| Debt to Equity | - | 0.90x | 2.52x | 3.80x | - | 3.74x | 3.57x | 2.02x | 1.34x | 1.62x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ardent Health Partners, Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 175M | 1.22 | 92.5% |
| 2021 | USD 62.1M | 0.43 | 40.3% |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
| 2015 | USD 559M | 3.96 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ardent Health Partners, Inc.
- Insiders 23.86%
- Institutions 76.14%
- Public & others 0.00%
- Shares outstanding 141M
- Free float 21.7M
Top funds holding ARDT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Columbia Small Cap Value Discv A | 1.04M | 0.74% | +0.73% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 896K | 0.64% | +35.37% | Sep 2026 |
| Avantis US Small Cap Value ETF | 865K | 0.61% | +1.65% | Oct 2026 |
| iShares Russell 2000 ETF | 630K | 0.45% | 0.00% | Oct 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 557K | 0.40% | 0.00% | Oct 2026 |
| Columbia Sm Cp Val and Inflection Inst | 450K | 0.32% | 0.00% | Sep 2026 |
| First Trust Small Cap Core AlphaDEX® ETF | 326K | 0.23% | 0.00% | Oct 2026 |
| Bridgeway Omni Small-Cap Value N | 290K | 0.21% | -26.59% | Jun 2026 |
| Fidelity Small Cap Index | 259K | 0.18% | 0.00% | Aug 2026 |
| iShares Russell 2000 Value ETF | 231K | 0.16% | 0.00% | Oct 2026 |
| DFA U.S. Small Cap Value I | 206K | 0.15% | +295.39% | Sep 2026 |
| Columbia VP Small Cap Value Discovery 1 | 183K | 0.13% | 0.00% | Sep 2026 |
| American Beacon Small Cp Val R5 | 179K | 0.13% | -2.14% | Sep 2026 |
| WisdomTree US SmallCap Earnings ETF | 168K | 0.12% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 137K | 0.10% | +1.06% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 131K | 0.09% | +0.22% | Oct 2026 |
| Dimensional US Small Cap Value ETF | 125K | 0.09% | +1.96% | Sep 2026 |
| Hotchkis & Wiley Sm Cp Divers Val I | 124K | 0.09% | 0.00% | Sep 2026 |
| Fidelity Extended Market Index | 114K | 0.08% | -11.08% | Sep 2026 |
| Vanguard US Multifactor ETF | 87.1K | 0.06% | +380.04% | Sep 2026 |
Top institutions holding ARDT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Chai Trust Co., LLC | 77.2M | 54.81% | 0.00% | Jun 2026 |
| Ventas Inc | 9.34M | 6.63% | 0.00% | Jun 2026 |
| BlackRock Inc | 2.18M | 1.54% | +23.78% | Jun 2026 |
| Ameriprise Financial Inc | 2.11M | 1.50% | +18.79% | Jun 2026 |
| Goldentree Asset Management LP | 1.58M | 1.12% | -31.38% | Jun 2026 |
| AQR Capital Management LLC | 1.45M | 1.03% | +53.64% | Jun 2026 |
| CastleKnight Management LP | 1.08M | 0.76% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 964K | 0.68% | -4.42% | Jun 2026 |
| Bridgeway Capital Management, LLC | 841K | 0.60% | -9.62% | Jun 2026 |
| Geode Capital Management, LLC | 621K | 0.44% | +10.60% | Jun 2026 |
| Algert Global LLC | 598K | 0.42% | +1,277.29% | Jun 2026 |
| State Street Corp | 566K | 0.40% | -3.39% | Jun 2026 |
| First Trust Advisors L.P. | 562K | 0.40% | +17.44% | Jun 2026 |
| Empowered Funds, LLC | 551K | 0.39% | +2.88% | Jun 2026 |
| Sageview Advisory Group LLC | 480K | 0.34% | -25.00% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 479K | 0.34% | +230.81% | Sep 2026 |
| Hotchkis & Wiley Capital Management LLC | 445K | 0.32% | +0.52% | Jun 2026 |
| UBS Group AG | 443K | 0.31% | -1.79% | Jun 2026 |
| Bank of America Corp | 390K | 0.28% | +8.09% | Jun 2026 |
| WEDGE Capital Management, LLP | 327K | 0.23% | +212.27% | Jun 2026 |
Ardent Health Partners, Inc. company profile
- Company name
- Ardent Health Partners, Inc.
- Ticker
- ARDT.US
- Exchange
- USA Stocks
- Listed since
- Jul 18, 2024
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 19,500
- Fiscal year end
- December
- Address
- 340 Seven Springs Way, Brentwood, TN, United States, 37027
- Phone
- 615 296 3000
- Website
- ardenthealth.com
About Ardent Health Partners, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Ardent Health Partners, Inc. management
10- Mr. David CaspersPresident, CEO & Director · born 1971
- Mr. Alfred Lumsdaine CPAChief Financial Officer · born 1965
- Mr. Stephen Christopher PetrovichExecutive VP, General Counsel & Secretary · born 1967
- Mr. David Byers CPASenior VP & Chief Accounting Officer · born 1981
- Mr. Lonnie Garrison PMPChief Technology Officer
- Mr. Gaurav KhannaChief Digital and Information Officer
- Ms. Caitlin FranklinChief Administrative Officer
- Mr. David Anthony Styblo C.F.A.Senior Vice President of Investor Relations
- Mr. Jason EhrlinspielChief Compliance Officer · born 1971
- Ms. Cheryl ChisholmChief People Officer